Iran's Supreme Leader met security chief Mohsen Rezaei and pushed for Iran's conditions to end the war, per Reuters citing ...

Semiconductors are whipsawing into the Fed. The Philadelphia Semiconductor Index plunged 6.7% on October 22, with $Advanced Micro Devices (AMD.US)$, $Intel (INTC.US)$ and $Marvell Technology ...

The US stock market rallied on Monday, 26 October 2026, primarily because investors returned to AI and semiconductor stocks ...

By Chancy $Meta Platforms (META.US)$ slipped about 1% Tuesday, trading near $623 despite $NVIDIA (NVDA.US)$ ’s announced $3 billion investment and deeper AI partnership. Meanwhile, an aggressive $7.5 ...

Tap the related stocks on the image above to add them to your Watchlist. ## What Happened Anthropic formally submitted its IPO application, per Futu's market digest. $Oracle (ORCL.US)$ expanded its ...

By Troncoparati Picture this. Meta is about to drop its Q3 numbers on October 21. Microsoft and Alphabet follow around the 28th. Amazon shows up the next day. Then Apple reports on November 2, which ...

Rates Volatility Gap Narrows Yesterday, we highlighted the risk of a volatility decoupling between equities and rates, with the bond market potentially pricing risks that equities have not fully ...

The past two trading sessions saw a sharp decline across growth and technology stocks. During the 2 days pullback, the S&P 500 fell approximately 2.2%, while the Nasdaq Composite dropped 4.0% as high ...

Just one day after the brutal sell-off in US technology and semiconductor stocks, TSMC (NYSE: TSM) has delivered another extraordinary quarter, beating market expectations and reinforcing its ...

Chips Just Had Their Worst Week Since Early 2025. Is the Bounce Real? Evening all. Tech is rebounding after a brutal week.

Alphabet-C (GOOG.US)$$Affirm Holdings (AFRM.US)$$Upstart (UPST.US)$$SPDR S&P 500 ETF (SPY.US)$$Invesco QQQ Trust (QQQ.US)$$Advanced Micro Devices (AMD.US)$$Micron Technology (MU.US)$ NEW YORK, October ...

AbbVie hit its Phase 3 goal, but a statistical win and a clear win are not the same thing, and the gap is the story. AbbVie said its experimental drug lutikizumab met the main goal of the Phase 3 ...